| Hematology | Lifetime | 77 | US 52 | 99.57 |
| Public, Environmental and Occupational Health | Lifetime | 427 | US 214 | 99.39 |
| Medical Genetics | Lifetime | 413 | US 211 | 96.46 |
| Hematology | 2021-2025 | 35 | US 17 | 99.29 |
| Public, Environmental and Occupational Health | 2021-2025 | 174 | US 68 | 98.55 |
| Medical Genetics | 2021-2025 | 156 | US 70 | 93.87 |
| Acute Lymphoblastic Leukemia research | Lifetime | 37 | US 30 | 99.75 |
| Acute Myeloid Leukemia Research | Lifetime | 71 | US 44 | 99.73 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 54 | US 39 | 99.66 |
| Hematopoietic Stem Cell Transplantation | Lifetime | 87 | US 54 | 99.50 |
| Multiple Myeloma Research and Treatments | Lifetime | 157 | US 83 | 98.96 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 110 | US 56 | 99.02 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 341 | US 171 | 99.02 |
| CAR-T cell therapy research | Lifetime | 456 | US 277 | 98.66 |
| Neutropenia and Cancer Infections | Lifetime | 169 | US 86 | 98.23 |
| Childhood Cancer Survivors' Quality of Life | Lifetime | 454 | US 241 | 97.84 |
| Retinoids in leukemia and cellular processes | Lifetime | 289 | US 159 | 97.40 |
| Lymphoma Diagnosis and Treatment | Lifetime | 884 | US 381 | 97.99 |
| Eosinophilic Disorders and Syndromes | Lifetime | 387 | US 183 | 97.15 |
| Hematological disorders and diagnostics | Lifetime | 740 | US 327 | 91.73 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 812 | US 331 | 92.56 |
| Acute Lymphoblastic Leukemia research | 2021-2025 | 21 | US 17 | 99.59 |
| Acute Myeloid Leukemia Research | 2021-2025 | 37 | US 28 | 99.60 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 23 | US 16 | 99.50 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 171 | US 86 | 97.91 |
| Hematopoietic Stem Cell Transplantation | 2021-2025 | 97 | US 49 | 98.05 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | 2021-2025 | 127 | US 74 | 96.73 |
| CAR-T cell therapy research | 2021-2025 | 922 | US 492 | 94.84 |
| Retinoids in leukemia and cellular processes | 2021-2025 | 72 | US 31 | 87.92 |
| Childhood Cancer Survivors' Quality of Life | 2021-2025 | 764 | US 352 | 90.02 |
| Neutropenia and Cancer Infections | 2021-2025 | 229 | US 84 | 85.85 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 354 | US 115 | 87.02 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 640 | US 238 | 79.81 |
| Hematological disorders and diagnostics | 2021-2025 | 354 | US 102 | 70.07 |
| Blood disorders and treatments | 2021-2025 | 803 | US 190 | 62.39 |
